Quick Answer
Altamira Therapeutics Ltd. reported Net Income of -$8.20 million for fiscal year 2020.
Altamira Therapeutics Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2020 | -$8.20M | -23.6% |
| 2019 | -$6.63M | +42.3% |
| 2018 | -$11.50M | — |
- Altamira Therapeutics Ltd. showed a decrease of -23.6% in Net Income compared to the prior fiscal year.
- Over the 2018–2020 period, Altamira Therapeutics Ltd.’s net income has grown by 28.7% (from -$11.50 million to -$8.20 million).
- The most recent figure is from Altamira Therapeutics Ltd.’s fiscal year 2020 report (Form 20-F), filed with the SEC on March 31, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: